ABSTRACT:Metabolism of pyridalyl [2,6-dichloro-4-(3,3-dichloroallyloxy)phenyl 3-[5-(trifluoromethyl)-2-pyridyloxy]propyl ether] was examined in male and female Sprague-Dawley rats. After a single oral administration of [dichlorophenyl-14 C]pyridalyl at 5 or 500 mg/kg, the 14 C concentration in blood reached maxima at 2 to 10 h and then decreased rapidly with a biological half-life of approximately 11 to 12 h. 14 C concentrations in liver, fat, adrenal gland, and spleen were relatively high at a low dose, reaching 2.3 to 2.7, 1.9 to 2.3, 1.1 to 1.9, and 1.4 ppm, respectively, in these tissues at 2 to 24 h after administration. Although 14 C elimination from fat and hair and skin was relatively slow compared with that from other tissues, the total residue on the 7th day was low, in the range of 1.3 to 2.3% of the dose. The 14 C distribution in tissues with a high dose, as examined by whole-body autoradiography, was similar to that observed for the low dose. Results revealed that more than 88% of the dosed radiocarbon was excreted within 1 day after administration, with cumulative 14 C excretion into urine and feces 7 days after administration of 1.7 to 2.6 and 98.7 to 101.7%, respectively. One urinary and fecal major metabolite (resulting from O-dealkylation) and two minor metabolites were identified by NMR and mass spectrometry. Residual 14 C in fat was extracted, and analysis by thin-layer chromatography showed it to be due to pyridalyl itself. No marked sex-related differences were observed in 14 C elimination, 14 C distribution, and metabolites.Pyridalyl [2,6-dichloro-4-(3,3-dichloroallyloxy)phenyl 3-[5-(trifluoromethyl)-2-pyridyloxy]propyl ether; S-1812] is a new class of insecticide for Lepidoptera and Thysanoptera (Sakamoto et al., 2004;Isayama et al., 2005). It has dichloropropenyl, phenyl and pyridyl groups in its structure but does not share structural similarity with other insecticides. Toxicity studies, including acute, chronic, oncogenicity, developmental, mutagenicity, and reproductive studies, have all been conducted previously with low acute toxicity, no oncogenicity and mutagenicity, and no teratogenicity observed (US Environmental Protection Agency, 2008).In the present study, metabolism of [dichlorophenyl-14 C]pyridalyl in rats was investigated in conjunction with toxicological studies for safety evaluation.14 C excretion, 14 C tissue distribution, and metabolites were investigated in support of rodent toxicology studies. The present report deals with metabolism ( 14 C excretion into feces, urine, and expired air, 14 C concentrations in tissues, and amounts of metabolites in excreta) of pyridalyl in rats.
Materials and Methods
Chemicals. [Dichlorophenyl-14 C]pyridalyl was prepared at the Environmental Health Science Laboratory of Sumitomo Chemical Co., Ltd. (Osaka, Japan) with a specific activity of 4.37 GBq/mmol. Labeled compound was purified with thin-layer chromatography (TLC) before use, and the radiochemical purity was Ͼ96.2%. Unlabeled pyridalyl (purity 98.4%) was also obtained from our co...